false
0001740332
0001740332
2026-08-03
2026-08-03
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported):
August 3, 2026
RESIDEO TECHNOLOGIES, INC.
(Exact name of registrant as specified in its
charter)
| Delaware |
|
001-38635 |
|
82-5318796 |
(State or other jurisdiction
of incorporation) |
|
(Commission File Number) |
|
(IRS Employer
Identification No.) |
| 16100 N. 71st Street, |
|
|
| Suite 550 |
|
|
| Scottsdale, Arizona |
|
85254 |
| (Address of principal executive offices) |
|
(Zip Code) |
Registrant’s telephone number, including
area code: (480) 573-5340
Registrant’s Former Name or Address, if
changed since last report: N/A
Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2.
below):
| ☐ |
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| ☐ |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| ☐ |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| ☐ |
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b) of the Act:
| Title of each class |
|
Trading Symbol(s) |
|
Name of each exchange on which registered |
| Common Stock, $0.001 Par Value |
|
REZI |
|
New York Stock Exchange |
Indicate by check mark whether the registrant is an emerging growth
company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange
Act of 1934 (§240.12b-2 of this chapter).
Emerging Growth Company ☐
If an emerging growth company, indicate by check mark if the registrant
has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant
to Section 13(a) of the Exchange Act. ☐
EXPLANATORY NOTE
This Current Report on Form 8-K is being filed
to provide the pro forma financial statements and the adjustments of the number of shares of Common Stock underlying outstanding awards and authorized for future issuance under certain
plans required under Items 2.01, 5.01 and 9.01 of Form 8-K in connection with the separation (the “Separation”)
from Resideo Technologies, Inc. (the “Company”) of its ADI Global Distribution business into an independent, publicly traded
company, ADI Global Distribution Inc. (NYSE:ADIG). The Separation was completed on August 3, 2026.
Item 5.02 Departure of Directors or Certain
Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
In connection with the separation by Resideo Technologies, Inc. (the “Company”) of the ADI Global Distribution
business from the Company's remaining businesses, effective as of August 3, 2026, the transfer of the ADI Global Distribution
business from the Company to ADI Global Distribution Inc. (“ADI”) and the distribution on a pro rata basis by the
Company of all of the outstanding shares of ADI's common stock, $0.001 par value per share, to holders of the Company's common
stock, $0.001 par value per share (the “Common Stock”), the number of shares of Common Stock underlying outstanding
awards and authorized for future issuance under the (i) Amended and Restated 2018 Stock Incentive Plan of Resideo Technologies, Inc.
and its Affiliates (the “Stock Incentive Plan”), (ii) 2018 Stock Plan for Non-Employee Directors of Resideo
Technologies, Inc. (the “Director Equity Plan”), and (iii) the Resideo Employee Stock Purchase Plan (the “Employee
Stock Purchase Plan” and, together with the Stock Incentive Plan and the Director Equity Plan, the “Plans”), were
adjusted to their current forms pursuant to the anti-dilution provisions of such plans, effective as of August 7, 2026 and each of
the Plans was amended in connection therewith to reflect the anti-dilution adjustment pursuant to each such Plan.
The above summary
does not purport to be complete and is qualified in its entirety by reference to the Stock Incentive Plan, the Director Equity Plan
and the Employee Stock Purchase Plan, which are filed as Exhibits 10.1, 10.2 and 10.3 to this Current Report on Form 8-K,
respectively, and are incorporated by reference herein.
Item 9.01.
Financial Statements and Exhibits
(d) Exhibits
The Company’s unaudited
pro forma condensed consolidated financial statements and related notes thereto, giving effect to the Separation, are filed as Exhibit
99.1 to this Current Report on Form 8-K and are incorporated herein by reference.
| Exhibit
No. |
|
Description |
| 10.1 |
|
Amended and Restated 2018 Stock Incentive Plan of Resideo Technologies, Inc. and its Affiliates |
| 10.2 |
|
2018 Stock Plan for Non-Employee Directors of Resideo Technologies, Inc. |
| 10.3 |
|
Resideo Employee Stock Purchase Plan |
| 10.4 |
|
Restricted Stock Unit Adjustment Notice under the Amended and Restated 2018 Stock Incentive Plan of Resideo Technologies, Inc. and its Affiliates |
| 10.5 |
|
Performance Stock Unit Adjustment Notice under the Amended and Restated 2018 Stock Incentive Plan of Resideo Technologies, Inc. and its Affiliates (2024 PSUs) |
| 10.6 |
|
Performance Stock Unit Adjustment Notice under the Amended and Restated 2018 Stock Incentive Plan of Resideo Technologies, Inc. and its Affiliates (2025 ROIC PSUs) |
| 10.7 |
|
Performance Stock Unit Adjustment Notice under the Amended and Restated 2018 Stock Incentive Plan of Resideo Technologies, Inc. and its Affiliates (2025 rTSR PSUs) |
| 10.8 |
|
Performance Stock Unit Adjustment Notice under the Amended and Restated 2018 Stock Incentive Plan of Resideo Technologies, Inc. and its Affiliates (2026 PSUs) |
| 10.9 |
|
Option Adjustment Notice under the Amended and Restated 2018 Stock Incentive Plan of Resideo Technologies, Inc. and its Affiliates |
| 99.1 |
|
Unaudited pro forma condensed consolidated financial statements of Resideo Technologies, Inc. |
| 104 |
|
Cover Page Interactive Data File (embedded within the Inline XBRL document). |
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934,
the Registrant has duly caused this Report to be signed on its behalf by the undersigned hereunto duly authorized.
| RESIDEO TECHNOLOGIES, INC. |
|
| |
|
|
| By: |
/s/ Joshua Foster |
|
| Name: |
Joshua Foster |
|
| Title: |
Senior Vice President, General Counsel and Corporate Secretary |
|
Date: August 7, 2026
Exhibit 99.1
UNAUDITED PRO FORMA
CONDENSED CONSOLIDATED FINANCIAL INFORMATION
On August 3, 2026, Resideo Technologies Inc. (“Resideo”,
the “Company”, “we”, “our” and “us”) completed the previously announced separation (the
“Separation”) of our former wholesale distribution business into a separate, independent publicly traded company, ADI Global
Distribution Inc. (“ADI”). The Separation was structured as a tax free spin-off, which occurred by way of a pro rata distribution
(the “Distribution”) of 100% of ADI common stock to Resideo common stockholders. Each Resideo common stockholder received
one share of ADI common stock for every two shares of Resideo common stock held as of July 20, 2026. ADI is now an independent publicly
traded company under the symbol “ADIG” on the New York Stock Exchange.
Resideo entered into various agreements to effect
the Separation and provide for the relationship between Resideo and ADI, including, among others, a separation and distribution agreement,
tax matters agreement, commercial product purchase agreement, employee matters agreement and transition services agreement.
The unaudited Pro Forma Condensed Consolidated
Financial Statements have been derived from the Company’s historical consolidated financial statements and gives effect to the Separation.
The following unaudited Pro Forma Condensed Consolidated Statements of Operations for the three months ended April 4, 2026 and for each
of the years ended December 31, 2025, 2024, and 2023 reflect the Company’s results of operations as if the Separation had occurred
as of January 1, 2023 in that they reflect the reclassification of ADI as discontinued operations for all periods presented. The adjustments
in the “Transaction Accounting Adjustments” column in the unaudited Pro Forma Condensed Consolidated Statements of Operations
for the three months ended April 4, 2026 and for the year ended December 31, 2025 give effect to the Separation and related transactions
as if they had occurred as of January 1, 2025. As a result, there are no transaction accounting adjustments for the years ended December
31, 2024 and 2023, respectively. The unaudited Pro Forma Condensed Consolidated Balance Sheet as of April 4, 2026 reflects the Company’s
financial position as if the Separation had occurred on April 4, 2026.
After the date of the Separation, Resideo no longer
consolidates ADI into its financial results. The historical financial results of ADI will be reflected in the Company’s consolidated
financial statements as discontinued operations under U.S. generally accepted accounting principles (“U.S. GAAP”) for all
periods.
The unaudited pro forma condensed consolidated
financial statements have been prepared based upon management’s estimates and assumptions using the best available information and
are subject to adjustments described below and in the accompanying notes. The unaudited pro forma condensed consolidated financial statements
are presented for illustrative and informational purposes only and are not necessarily indicative of the financial position or results
of operations had the Separation and related transactions been completed on the date assumed, nor are they indicative of the Company’s
future financial position or results of operations. The unaudited pro forma condensed consolidated financial statements should be read
in conjunction with the Company’s historical consolidated financial statements and accompanying notes. The adjustments included
within the “ADI Separation” column are consistent with the guidance for discontinued operations under U.S. GAAP. The Company's
current estimates on a discontinued operations basis are preliminary and could change as the Company finalizes discontinued operations
accounting to be reported in the Company's 2026 Annual Report on Form 10-K and applicable 2026 Quarterly Reports on Form 10-Q.
The unaudited pro forma condensed consolidated
financial statements have been prepared in accordance with Regulation S-X Article 11, Pro Forma Financial Information.
Unaudited Pro Forma Condensed Consolidated
Balance Sheet
As of April 4, 2026
| ($ in millions) | |
Historical
Resideo
(as reported) | | |
ADI
Discontinued
Operations
(Note a) | | |
Transaction
Accounting
Adjustments | | |
Notes | |
Pro Forma
Resideo | |
| Assets: | |
| | |
| | |
| | |
| |
| |
| Current assets: | |
| | |
| | |
| | |
| |
| |
| Cash and cash equivalents | |
$ | 438 | | |
$ | (135 | ) | |
$ | (133 | ) | |
(b) | |
$ | 170 | |
| Accounts receivable, net | |
| 1,114 | | |
| (703 | ) | |
| - | | |
| |
| 411 | |
| Inventories, net | |
| 1,357 | | |
| (1,036 | ) | |
| - | | |
| |
| 321 | |
| Other current assets | |
| 265 | | |
| (146 | ) | |
| - | | |
| |
| 119 | |
| Total current assets | |
| 3,174 | | |
| (2,020 | ) | |
| (133 | ) | |
| |
| 1,021 | |
| | |
| | | |
| | | |
| | | |
| |
| | |
| Property, plant and equipment, net | |
| 444 | | |
| (107 | ) | |
| - | | |
| |
| 337 | |
| Goodwill | |
| 3,096 | | |
| (1,065 | ) | |
| - | | |
| |
| 2,031 | |
| Intangible assets, net | |
| 1,069 | | |
| (725 | ) | |
| - | | |
| |
| 344 | |
| Other assets | |
| 424 | | |
| (173 | ) | |
| - | | |
| |
| 251 | |
| Total Assets | |
$ | 8,207 | | |
$ | (4,090 | ) | |
$ | (133 | ) | |
| |
$ | 3,984 | |
| | |
| | | |
| | | |
| | | |
| |
| | |
| Liabilities and Stockholders’ equity: | |
| | | |
| | | |
| | | |
| |
| | |
| Current liabilities: | |
| | | |
| | | |
| | | |
| |
| | |
| Accounts payable | |
$ | 1,015 | | |
$ | (610 | ) | |
$ | - | | |
| |
$ | 405 | |
| Accrued liabilities | |
| 516 | | |
| (175 | ) | |
| 54 | | |
(c) | |
| 395 | |
| Total current liabilities | |
| 1,531 | | |
| (785 | ) | |
| 54 | | |
| |
| 800 | |
| | |
| | | |
| | | |
| | | |
| |
| | |
| Long-term debt | |
| 3,165 | | |
| - | | |
| (1,100 | ) | |
(b) | |
| 2,065 | |
| Other liabilities | |
| 589 | | |
| (239 | ) | |
| - | | |
| |
| 350 | |
| Total liabilities | |
| 5,285 | | |
| (1,024 | ) | |
| (1,046 | ) | |
| |
| 3,215 | |
| | |
| | | |
| | | |
| | | |
| |
| | |
| Stockholders’ equity: | |
| | | |
| | | |
| | | |
| |
| | |
| Preferred stock | |
| 482 | | |
| - | | |
| - | | |
| |
| 482 | |
| Common stock | |
| - | | |
| - | | |
| - | | |
| |
| - | |
| Additional paid-in capital | |
| 2,410 | | |
| - | | |
| - | | |
| |
| 2,410 | |
| Retained earnings | |
| 374 | | |
| (3,111 | ) | |
| 913 | | |
(d) | |
| (1,824 | ) |
| Accumulated other comprehensive income/(loss) | |
| (168 | ) | |
| 45 | | |
| - | | |
| |
| (123 | ) |
| Treasury stock at cost | |
| (176 | ) | |
| - | | |
| - | | |
| |
| (176 | ) |
| Total stockholders’ equity | |
| 2,922 | | |
| (3,066 | ) | |
| 913 | | |
| |
| 769 | |
| Total liabilities and stockholders’ equity | |
$ | 8,207 | | |
$ | (4,090 | ) | |
$ | (133 | ) | |
| |
$ | 3,984 | |
Unaudited Pro Forma Condensed Consolidated
Statement of Operations
For the Three Months Ended April 4, 2026
| ($ in millions except per share amounts) | |
Historical
Resideo
(as reported) | | |
ADI
Discontinued
Operations
(Note a) | | |
Transaction
Accounting
Adjustments | | |
Notes | |
Pro Forma
Resideo | |
| Net revenue | |
$ | 1,912 | | |
$ | (1,160 | ) | |
$ | - | | |
| |
$ | 752 | |
| Cost of goods sold | |
| 1,361 | | |
| (904 | ) | |
| - | | |
| |
| 457 | |
| Gross profit | |
| 551 | | |
| (256 | ) | |
| - | | |
| |
| 295 | |
| Operating expenses: | |
| | | |
| | | |
| | | |
| |
| | |
| Research and development expenses | |
| 48 | | |
| (11 | ) | |
| - | | |
| |
| 37 | |
| Selling, general and administrative expenses | |
| 340 | | |
| (190 | ) | |
| - | | |
| |
| 150 | |
| Intangible asset amortization | |
| 31 | | |
| (24 | ) | |
| - | | |
| |
| 7 | |
| Restructuring expenses | |
| 6 | | |
| - | | |
| - | | |
| |
| 6 | |
| Business separation costs | |
| 24 | | |
| (24 | ) | |
| - | | |
| |
| - | |
| Total operating expenses | |
| 449 | | |
| (249 | ) | |
| - | | |
| |
| 200 | |
| Income from operations | |
| 102 | | |
| (7 | ) | |
| - | | |
| |
| 95 | |
| Interest expense, net | |
| 47 | | |
| (14 | ) | |
| (3 | ) | |
(e) | |
| 30 | |
| Net income before taxes | |
| 55 | | |
| 7 | | |
| 3 | | |
| |
| 65 | |
| Provision for income taxes | |
| 17 | | |
| 3 | | |
| 1 | | |
(f) | |
| 21 | |
| Net income | |
| 38 | | |
| 4 | | |
| 2 | | |
| |
| 44 | |
| Less: preferred stock dividends | |
| 9 | | |
| - | | |
| - | | |
| |
| 9 | |
| Less: undistributed income allocated to preferred stockholders | |
| 3 | | |
| - | | |
| - | | |
| |
| 3 | |
| Net income available to common stockholders | |
$ | 26 | | |
$ | 4 | | |
$ | 2 | | |
| |
$ | 32 | |
| | |
| | | |
| | | |
| | | |
| |
| | |
| Earnings per common share: | |
| | | |
| | | |
| | | |
| |
| | |
| Basic | |
$ | 0.17 | | |
| | | |
| | | |
| |
$ | 0.21 | |
| Diluted | |
$ | 0.17 | | |
| | | |
| | | |
| |
$ | 0.21 | |
| | |
| | | |
| | | |
| | | |
| |
| | |
| Weighted average common shares outstanding | |
| | | |
| | | |
| | | |
| |
| | |
| Basic | |
| 151 | | |
| | | |
| | | |
| |
| 151 | |
| Diluted | |
| 155 | | |
| | | |
| | | |
| |
| 155 | |
Unaudited Pro Forma Condensed Consolidated
Statement of Operations
For the year Ended December 31, 2025
| ($ in millions except per share amounts) |
|
Historical
Resideo
(as reported) |
|
|
ADI
Discontinued
Operations
(Note a) |
|
|
Transaction
Accounting
Adjustments |
|
|
Notes |
|
Pro Forma
Resideo |
|
| Net revenue |
|
$ |
7,472 |
|
|
$ |
(4,614 |
) |
|
$ |
- |
|
|
|
|
$ |
2,858 |
|
| Cost of goods sold |
|
|
5,276 |
|
|
|
(3,549 |
) |
|
|
- |
|
|
|
|
|
1,727 |
|
| Gross profit |
|
|
2,196 |
|
|
|
(1,065 |
) |
|
|
- |
|
|
|
|
|
1,131 |
|
| Operating expenses: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Research and development expenses |
|
|
167 |
|
|
|
(39 |
) |
|
|
- |
|
|
|
|
|
128 |
|
| Selling, general and administrative expenses |
|
|
1,266 |
|
|
|
(725 |
) |
|
|
- |
|
|
|
|
|
541 |
|
| Intangible asset amortization |
|
|
122 |
|
|
|
(94 |
) |
|
|
- |
|
|
|
|
|
28 |
|
| Restructuring, impairment and extinguishment costs |
|
|
16 |
|
|
|
(8 |
) |
|
|
- |
|
|
|
|
|
8 |
|
| Business separation costs |
|
|
18 |
|
|
|
(18 |
) |
|
|
- |
|
|
|
|
|
- |
|
| Total operating expenses |
|
|
1,589 |
|
|
|
(884 |
) |
|
|
- |
|
|
|
|
|
705 |
|
| Income from operations |
|
|
607 |
|
|
|
(181 |
) |
|
|
- |
|
|
|
|
|
426 |
|
| Indemnification Agreement expense |
|
|
972 |
|
|
|
- |
|
|
|
- |
|
|
|
|
|
972 |
|
| Other expense (income), net |
|
|
(43 |
) |
|
|
3 |
|
|
|
- |
|
|
|
|
|
(40 |
) |
| Interest expense, net |
|
|
135 |
|
|
|
(21 |
) |
|
|
(5 |
) |
|
(e) |
|
|
109 |
|
| Net income (loss) before taxes |
|
|
(457 |
) |
|
|
(163 |
) |
|
|
5 |
|
|
|
|
|
(615 |
) |
| Provision for income taxes |
|
|
70 |
|
|
|
(51 |
) |
|
|
1 |
|
|
(f) |
|
|
20 |
|
| Net income (loss) |
|
|
(527 |
) |
|
|
(112 |
) |
|
|
4 |
|
|
|
|
|
(635 |
) |
| Less: preferred stock dividends |
|
|
35 |
|
|
|
- |
|
|
|
- |
|
|
|
|
|
35 |
|
| Less: undistributed income allocated to preferred stockholders |
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
|
|
- |
|
| Net income (loss) available to common stockholders |
|
$ |
(562 |
) |
|
$ |
(112 |
) |
|
$ |
4 |
|
|
|
|
$ |
(670 |
) |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Earnings (loss) per common share: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Basic |
|
$ |
(3.77 |
) |
|
|
|
|
|
|
|
|
|
|
|
$ |
(4.50 |
) |
| Diluted |
|
$ |
(3.77 |
) |
|
|
|
|
|
|
|
|
|
|
|
$ |
(4.50 |
) |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Weighted average common shares outstanding |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Basic |
|
|
149 |
|
|
|
|
|
|
|
|
|
|
|
|
|
149 |
|
| Diluted |
|
|
149 |
|
|
|
|
|
|
|
|
|
|
|
|
|
149 |
|
Unaudited Pro Forma Condensed Consolidated
Statement of Operations
For the Year Ended December 31, 2024
| ($ in millions except per share amounts) | |
Historical
Resideo
(as reported) | | |
ADI
Discontinued
Operations
(Note a) | | |
Pro Forma
Resideo | |
| Net revenue | |
$ | 6,761 | | |
$ | (4,012 | ) | |
$ | 2,749 | |
| Cost of goods sold | |
| 4,860 | | |
| (3,161 | ) | |
| 1,699 | |
| Gross profit | |
| 1,901 | | |
| (851 | ) | |
| 1,050 | |
| Operating expenses: | |
| | | |
| | | |
| | |
| Research and development expenses | |
| 111 | | |
| (17 | ) | |
| 94 | |
| Selling, general and administrative expenses | |
| 1,138 | | |
| (603 | ) | |
| 535 | |
| Intangible asset amortization | |
| 80 | | |
| (54 | ) | |
| 26 | |
| Restructuring, impairment and extinguishment costs | |
| 52 | | |
| (20 | ) | |
| 32 | |
| Total operating expenses | |
| 1,381 | | |
| (694 | ) | |
| 687 | |
| Income from operations | |
| 520 | | |
| (157 | ) | |
| 363 | |
| Indemnification Agreement expense | |
| 211 | | |
| - | | |
| 211 | |
| Other expense (income), net | |
| 7 | | |
| (3 | ) | |
| 4 | |
| Interest expense, net | |
| 81 | | |
| 3 | | |
| 84 | |
| Net income (loss) before taxes | |
| 221 | | |
| (157 | ) | |
| 64 | |
| Provision for income taxes | |
| 105 | | |
| (43 | ) | |
| 62 | |
| Net income (loss) | |
| 116 | | |
| (114 | ) | |
| 2 | |
| Less: preferred stock dividends | |
| 19 | | |
| - | | |
| 19 | |
| Less: undistributed income allocated to preferred stockholders | |
| 6 | | |
| - | | |
| 6 | |
| Net income (loss) available to common stockholders | |
$ | 91 | | |
$ | (114 | ) | |
$ | (23 | ) |
| | |
| | | |
| | | |
| | |
| Earnings (loss) per common share: | |
| | | |
| | | |
| | |
| Basic | |
$ | 0.62 | | |
| | | |
$ | (0.16 | ) |
| Diluted | |
$ | 0.61 | | |
| | | |
$ | (0.16 | ) |
| | |
| | | |
| | | |
| | |
| Weighted average common shares outstanding: | |
| | | |
| | | |
| | |
| Basic | |
| 146 | | |
| | | |
| 146 | |
| Diluted | |
| 149 | | |
| | | |
| 146 | |
Unaudited Pro Forma Condensed Consolidated
Statement of Operations
For the Year Ended December 31, 2023
| ($ in millions except per share amounts) |
|
Historical Resideo (as reported) |
|
|
ADI Discontinued Operations (Note a) |
|
|
Pro Forma Resideo |
|
| Net revenue |
|
$ |
6,242 |
|
|
$ |
(3,275 |
) |
|
$ |
2,967 |
|
| Cost of goods sold |
|
|
4,546 |
|
|
|
(2,607 |
) |
|
|
1,939 |
|
| Gross profit |
|
|
1,696 |
|
|
|
(668 |
) |
|
|
1,028 |
|
| Operating expenses: |
|
|
|
|
|
|
|
|
|
|
|
|
| Research and development expenses |
|
|
109 |
|
|
|
- |
|
|
|
109 |
|
| Selling general and administrative expenses |
|
|
960 |
|
|
|
(416 |
) |
|
|
544 |
|
| Intangible asset amortization |
|
|
38 |
|
|
|
(11 |
) |
|
|
27 |
|
| Restructuring, impairment and extinguishment costs |
|
|
42 |
|
|
|
(12 |
) |
|
|
30 |
|
| Total operating expenses |
|
|
1,149 |
|
|
|
(439 |
) |
|
|
710 |
|
| Income from operations |
|
|
547 |
|
|
|
(229 |
) |
|
|
318 |
|
| Indemnification Agreement expense |
|
|
178 |
|
|
|
- |
|
|
|
178 |
|
| Other expense (income), net |
|
|
(9 |
) |
|
|
8 |
|
|
|
(1 |
) |
| Interest expense, net |
|
|
65 |
|
|
|
2 |
|
|
|
67 |
|
| Net income before taxes |
|
|
313 |
|
|
|
(239 |
) |
|
|
74 |
|
| Provision for income taxes |
|
|
103 |
|
|
|
(65 |
) |
|
|
38 |
|
| Net income |
|
|
210 |
|
|
|
(174 |
) |
|
|
36 |
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
| Earnings per common share: |
|
|
|
|
|
|
|
|
|
|
|
|
| Basic |
|
$ |
1.43 |
|
|
|
|
|
|
$ |
0.24 |
|
| Diluted |
|
$ |
1.42 |
|
|
|
|
|
|
$ |
0.24 |
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
| Weighted average common shares outstanding: |
|
|
|
|
|
|
|
|
|
|
|
|
| Basic |
|
|
147 |
|
|
|
|
|
|
|
147 |
|
| Diluted |
|
|
148 |
|
|
|
|
|
|
|
148 |
|
NOTES TO UNAUDITED
PRO FORMA CONDENSED Consolidated FINANCIAL STATEMENTS
ADI Discontinued Operations
| (a) | Reflects the discontinued operations of ADI, including the associated assets, liabilities, equity and results of operations in accordance
with ASC 205-20, Presentation of Financial Statements – Discontinued Operations. The adjustment amounts do not include general
corporate overhead costs which were historically allocated, but did not specifically relate to ADI, as they did not meet the discontinued
operations criteria. Such allocations include labor and non-labor expenses related to Resideo’s corporate support functions (e.g.,
information technology, human resources, legal, finance, accounting, insurance, employee benefits, tax, among others) that historically
provided support to ADI. |
Transaction Accounting Adjustments
| (b) | Reflects the distribution of $967 million of cash from ADI to Resideo in connection with the Separation, consisting of a $900 million
cash dividend and a $67 million cash adjustment pursuant to the Separation Agreement, after retaining $150 million of cash at ADI. The
proceeds are expected to be used, together with Resideo's cash on hand, to repay approximately $1.1 billion of Term Loan B facilities. |
| ($ in millions) |
|
As of April 4, 2026 |
|
| Cash dividend received from ADI |
|
$ |
900 |
|
| Cash adjustment distribution from ADI pursuant to Separation Agreement |
|
|
67 |
|
| Less: repayment of Term Loan B facilities |
|
|
(1,100 |
) |
| Total pro forma adjustment to cash and cash equivalents |
|
$ |
(133 |
) |
| (c) | Reflects the accrual for additional estimated costs of $54 million related to transaction advisory and professional services, regulatory
filings, separation activities and other costs directly attributable to the Separation that anticipated to be incurred between April 4,
2026 and the distribution date. These costs are reflected as an accrual on the unaudited Pro Forma Condensed Consolidated Balance Sheet,
with the offsetting entry recorded to retained earnings. Because these costs will be recognized as a component of discontinued operations
when incurred following the Separation, no corresponding adjustment is reflected in the unaudited Pro Forma Condensed Consolidated Statement
of Operations. |
| (d) | Reflects the effect on total shareholders' equity of the adjustments described in notes (b) and (c) above. |
| (e) | Reflects the reduction of incremental Term Loan B interest expense of $3 million and $5 million for the three months ended April 4,
2026, and the year ended December 31, 2025, respectively, to give effect to the estimated repayment of the remaining Term Loan B debt
described in (b) above. Interest expense and the related amortization of debt issuance costs of $15 million and $23 million for the three
months ended April 4, 2026, and the year ended December 31, 2025, respectively, associated with the portion of the Term Loan B required
to be repaid in connection with the disposal is reflected in the ADI Discontinued Operations (see note (a) above). |
| (f) | Reflects the income tax effects of the pro forma adjustments for the three months ended April 4, 2026 and the year ended December
31, 2025. The adjustments were calculated using the applicable statutory tax rates. Actual tax effects may differ depending on the legal
entity structure and other factors following the Separation. |
Additionally, in connection with the Separation, Resideo and ADI entered
into a transition services agreement whereby Resideo and ADI will each provide certain post-closing services to each other on a transitional
basis. Such agreements are not expected to have a material impact on the periods presented in these unaudited Pro Forma Condensed Consolidated
Financial Statements.